LOGO
SUBSCRIBE NOW

Week 2

IV. Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial
26
Jan
97

Please summarise this article What is the level of evidence provided by this article? View / Download

Posted in: Post-transplant Long-term Complications , Week 2 ,
III. Post-transplantation lymphoproliferative disorders: Current concepts and future therapeutic approaches
26
Jan
120

Please summarise this article What is the level of evidence provided by this article? View / Download

Posted in: Post-transplant Long-term Complications , Week 2 ,
II. Front-line management of post-transplantation lymphoproliferative disorder in adult solid organ recipient patients — A British Society for Haematology Guideline
26
Jan
117

Please summarise this article View / Download

Posted in: Post-transplant Long-term Complications , Week 2 ,
I. Adoptive cellular immunotherapy for Epstein-Barr virus-associated lymphoproliferative disease
26
Jan
118

Briefly summarise the principle of adoptive immunotherapy in the treatment of PTLD What are the indications of adoptive immunotherapy? Can adoptive immunotherapy be used in the treatment of other conditions related to organ transplantation? What are the side effects of adoptive immunotherapy? View / Download

Posted in: Post-transplant Long-term Complications , Week 2 ,
5. A 65-year-old kidney transplant recipient developed this lesion 7 years after his cadaveric transplantation. Currently, he is on Tacrolimus (trough level 7.4 ng/ml) and MMF 750 mg bd. He has poor kidney function (eGFR is 15 ml/min) due to cAMR.
26
Jan
135

What is your differential diagnosis? How do you manage this case? Substantiate your answer.

Posted in: Post-transplant Long-term Complications , Week 2 ,
4. A 43-year-old CKD 5 patient who was on HD for 2 years secondary to unknown aetiology presented to you in the transplant clinic 1 year after his transplantation with this lesion on the right side of his neck (see below). He is currently on tacrolimus-based immunosuppression with excellent kidney function.
26
Jan
149

What is your differential diagnosis? Briefly outline his management

Posted in: Post-transplant Long-term Complications , Week 2 ,
3. A 46-year-old potential kidney donor came forward to donate to his brother. 111 mismatch, no DSA. CT showed angiomyolipoma in the left kidney (4.6 cm in diameter).
26
Jan
178

Will you accept this donor? What is angiomyolipoma? What are the risks involved? Is this image adequate? What are the other diseases associated with angiomyolipoma?

Posted in: Post-transplant Long-term Complications , Week 2 ,
2. A 51-year-old man with a history of right renal transplant presented with right-sided flank pain, chills, and fever. CT was performed in search of the source of infection.
26
Jan
173

What is your differential diagnosis? Please outline your management Are any other tests required?

Posted in: Post-transplant Long-term Complications , Week 2 ,
1. A 36-year-old man with a right renal transplant from his brother presented with loss of weight, night sweats, and night fever associated with deep pelvic discomfort. He has excellent kidney function. Currently, he is on Tacrolimus-based dual immunosuppression. His CT pelvis is shown below:
26
Jan
226

What is your differential diagnosis? Briefly outline his management

Posted in: Post-transplant Long-term Complications , Week 2 ,
LOGO

Credit To

ICOM

Follow Us

Copyright © 2024 World Kidney Academy. All Rights Reserved. ICOM

You cannot copy content of this page